Cervical intraepithelial neoplasia

WikiDoc Resources for Cervical intraepithelial neoplasia
Articles
Most recent articles on Cervical intraepithelial neoplasia Most cited articles on Cervical intraepithelial neoplasia Review articles on Cervical intraepithelial neoplasia Articles on Cervical intraepithelial neoplasia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cervical intraepithelial neoplasia Images of Cervical intraepithelial neoplasia Photos of Cervical intraepithelial neoplasia Podcasts & MP3s on Cervical intraepithelial neoplasia Videos on Cervical intraepithelial neoplasia
Evidence Based Medicine
Cochrane Collaboration on Cervical intraepithelial neoplasia Bandolier on Cervical intraepithelial neoplasia TRIP on Cervical intraepithelial neoplasia
Clinical Trials
Ongoing Trials on Cervical intraepithelial neoplasia at Clinical Trials.gov Trial results on Cervical intraepithelial neoplasia Clinical Trials on Cervical intraepithelial neoplasia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cervical intraepithelial neoplasia NICE Guidance on Cervical intraepithelial neoplasia NHS PRODIGY Guidance FDA on Cervical intraepithelial neoplasia CDC on Cervical intraepithelial neoplasia
Books
Books on Cervical intraepithelial neoplasia
News
Cervical intraepithelial neoplasia in the news Be alerted to news on Cervical intraepithelial neoplasia News trends on Cervical intraepithelial neoplasia
Commentary
Blogs on Cervical intraepithelial neoplasia
Definitions
Definitions of Cervical intraepithelial neoplasia
Patient Resources / Community
Patient resources on Cervical intraepithelial neoplasia Discussion groups on Cervical intraepithelial neoplasia Patient Handouts on Cervical intraepithelial neoplasia Directions to Hospitals Treating Cervical intraepithelial neoplasia Risk calculators and risk factors for Cervical intraepithelial neoplasia
Healthcare Provider Resources
Symptoms of Cervical intraepithelial neoplasia Causes & Risk Factors for Cervical intraepithelial neoplasia Diagnostic studies for Cervical intraepithelial neoplasia Treatment of Cervical intraepithelial neoplasia
Continuing Medical Education (CME)
CME Programs on Cervical intraepithelial neoplasia
International
Cervical intraepithelial neoplasia en Espanol Cervical intraepithelial neoplasia en Francais
Business
Cervical intraepithelial neoplasia in the Marketplace Patents on Cervical intraepithelial neoplasia
Experimental / Informatics
List of terms related to Cervical intraepithelial neoplasia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: CIN; cervical interstitial neoplasia; cervical dysplasia; cervical interstitial neoplasia

Historical Perspective

• Cervical intraepithelial neoplasia was first discovered by Dr. Georgios Nikolaou Papanikolaou, a Greek pathologist, in 1927.
• In 1928, the first screening was developed by Aurel Babeș, a Romanian pathologist to diagnose cervical intraepithelial neoplasia.
• In 1980, human papillomavirus (HPV) was first identified in the pathogenesis of cervical intraepithelial neoplasia.

Classification

• Cervical intraepithelial neoplasia has 4 cytological classifications: Bethesda system, Papanicolaou classification, CIN nomenclature, and dysplasia nomenclature.
• Cervical intraepithelial neoplasia may be classified according to Papanicolau into 3 subtypes:

• CIN1 (Grade I)
• CIN2 (Grade II)
• CIN3 (Grade III)

• Cervical intraepithelial neoplasia may be classified according to Bethesda system into 3 subtypes:

• Low grade squamous intraepithelial lesion (LGSIL)
• High grade squamous intraepithelial lesions (HSIL)
• Carcinoma in situ

• Other variants of cervical intraepithelial neoplasia include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of cervical intraepithelial neoplasia is characterized by the premalignant transformation and abnormal growth of squamous cells on the surface of the cervix.
• Cervical intraepithelial neoplasia arises from the squamous-columnar junction, which is also known as the "transformation zone".
• The "transformation zone" is where the squamous epithelium of the ectocervix joins the columnar epithelium of the endocervix.
• The presence of human papillomavirus (HPV) has a crucial role in the pathogenesis of cervical intraepithelial neoplasia.
• The first precursor lesion of cervical intraepithelial neoplasia is the koilocyte, which is a squamous epithelial cell that has undergone a number of structural changes (these usually occur as a result of infection of the cell by human papillomavirus).
• The viral replication of human papillomavirus (HPV) encodes proteins E6 and E7 which interfere with the normal epithelial cell functions. This leads to a deficient cell replication and excessive cell growth.
• On gross pathology, there are no characteristic findings of cervical intraepithelial neoplasia.
• On microscopic histopathological analysis, findings of cervical intraepithelial neoplasia will depend on the lesion grade.

Causes

• cervical intraepithelial neoplasia may be caused by either [cause1], [cause2], or [cause3].
• cervical intraepithelial neoplasia is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for cervical intraepithelial neoplasia.

Differentiating cervical intraepithelial neoplasia from other Diseases

• cervical intraepithelial neoplasia must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of cervical intraepithelial neoplasia is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of cervical intraepithelial neoplasia was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop cervical intraepithelial neoplasia.

• cervical intraepithelial neoplasia is more commonly observed among patients aged [age range] years old.
• cervical intraepithelial neoplasia is more commonly observed among [elderly patients/young patients/children].

Gender

• cervical intraepithelial neoplasia affects men and women equally.

• [Gender 1] are more commonly affected with cervical intraepithelial neoplasia than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for cervical intraepithelial neoplasia.

• cervical intraepithelial neoplasia usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop cervical intraepithelial neoplasia.

Risk Factors

• Common risk factors in the development of cervical intraepithelial neoplasia are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with cervical intraepithelial neoplasia remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with cervical intraepithelial neoplasia may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of cervical intraepithelial neoplasia include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with cervical intraepithelial neoplasia is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of cervical intraepithelial neoplasia is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• cervical intraepithelial neoplasia is usually asymptomatic.
• Symptoms of cervical intraepithelial neoplasia may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with cervical intraepithelial neoplasia usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with cervical intraepithelial neoplasia.

• A [positive/negative] [test name] is diagnostic of cervical intraepithelial neoplasia.
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of cervical intraepithelial neoplasia.
• Other laboratory findings consistent with the diagnosis of cervical intraepithelial neoplasia include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with cervical intraepithelial neoplasia.

• [Imaging study 1] is the imaging modality of choice for cervical intraepithelial neoplasia.
• On [imaging study 1], cervical intraepithelial neoplasia is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• cervical intraepithelial neoplasia may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for cervical intraepithelial neoplasia; the mainstay of therapy is supportive care.

• The mainstay of therapy for cervical intraepithelial neoplasia is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for cervical intraepithelial neoplasia.
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of cervical intraepithelial neoplasia.
• [Surgical procedure] can only be performed for patients with [disease stage] cervical intraepithelial neoplasia.

Prevention

• There are no primary preventive measures available for cervical intraepithelial neoplasia.

• Effective measures for the primary prevention of cervical intraepithelial neoplasia include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with cervical intraepithelial neoplasia are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].